[144] Telos Corporation SEC Filing

Rhea-AI Filing Summary

Telos Corporation (TLS) Form 144 filing notifies the market that 25,000 shares of common stock are proposed for sale through Morgan Stanley Smith Barney, with an aggregate market value of $156,402.50 and an approximate sale date of 08/25/2025. The filing reports 72,703,011 shares outstanding and shows the 25,000 shares were originally issued as restricted stock on 03/08/2023 by the issuer and paid for on that date.

The form also discloses a recent sale by Bradley Jacobs of 60,000 shares on 08/13/2025 for $313,200.00. The notice includes the standard representation that the seller does not possess undisclosed material adverse information.

Insights

Securities Analyst

TL;DR: Routine insider sale filing; modest volume relative to shares outstanding, likely neutral to valuation.

The Form 144 documents a proposed sale of 25,000 common shares through a major broker and discloses a prior 60,000-share sale by Bradley Jacobs generating $313,200. The 25,000-share lot represents a small fraction of the reported 72,703,011 shares outstanding (approximately 0.034%). The shares were acquired as restricted stock on 03/08/2023, indicating these are previously nonpublic shares now eligible for sale. From a market-impact perspective, the disclosed volumes appear limited relative to the issuer's capitalization, so the filing is informational and routine rather than transformative.

Corporate Governance Expert

TL;DR: Disclosure aligns with Rule 144 requirements; seller affirms no undisclosed material information.

The filing meets procedural requirements by naming the broker, stating the acquisition type (restricted stock), and certifying absence of undisclosed material information. The presence of recent sales by the same individual (60,000 on 08/13/2025) could be relevant to governance observers evaluating insider liquidity, but the form itself contains no statements of intent beyond the sale notice. There is no indication of any trading plan date or 10b5-1 adoption in the remarks.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	25000	156402.50	72703011	08/25/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/08/2023	Restricted Stock	Issuer			25000	03/08/2023	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
BRADLEY JACOBS 19886 Ashburn Road Ashburn VA 20147-2358	Common	08/13/2025	60000	313200.00

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Telos Corporation (TLS) disclose in this Form 144?

The filing discloses a proposed sale of 25,000 common shares through Morgan Stanley Smith Barney with an aggregate market value of $156,402.50 and an approximate sale date of 08/25/2025.

When and how were the 25,000 shares acquired?

The 25,000 shares were acquired as restricted stock on 03/08/2023 from the issuer, with payment recorded on that date.

Has the filer sold shares recently before this proposed sale?

Yes. The filing reports Bradley Jacobs sold 60,000 common shares on 08/13/2025 for gross proceeds of $313,200.00.

How large is the proposed sale relative to shares outstanding?

The filing reports 72,703,011 shares outstanding; the proposed 25,000-share sale is roughly 0.034% of that total.

Does the Form 144 indicate any undisclosed material information?

The signer represents they do not know any material adverse information regarding the issuer that has not been publicly disclosed.